Grown Rogue International (GRUSF) Common Equity (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Common Equity of $16.8 million for Q1 2026, up 10.44% year-over-year from $15.2 million in Q1 2025, and down 29.6% quarter-over-quarter from $23.9 million in Q4 2025.
Grown Rogue International (GRUSF) Common Equity (2009 - 2026) Analysis & Trends
Grown Rogue International's Common Equity history runs 18 years deep, the most recent figure standing at $16.8 million for Q1 2026.
- In Q1 2026, Common Equity rose 10.44% year-over-year to $16.8 million; the TTM figure through Mar 2026 stood at $16.8 million (up 10.44% YoY), while the FY2025 annual figure was $23.9 million, up 126.16% from the prior year.
- Common Equity for Q1 2026 stood at $16.8 million, down from $23.9 million in the prior quarter.
- The five-year high for Common Equity was $32239.6 billion in Q3 2025, with the low at -$0.01 in Q4 2023.
- The 5-year median for Common Equity is $10.6 million (2024), against an average of $2480.0 billion.
- The sharpest annual moves came in 2023 and 2025: Common Equity sank 100.0% in 2023, then surged 340581371.32% in 2025.
- Grown Rogue International's Common Equity stood at $6.7 million in 2022, then surged by 45.49% to $9.8 million in 2023, then gained by 8.0% to $10.6 million in 2024, then surged by 126.16% to $23.9 million in 2025, then decreased by 29.6% to $16.8 million in 2026.
- Business Quant data shows GRUSF's Common Equity at $16.8 million in Q1 2026, $23.9 million in Q4 2025, and $32239.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | 21.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.76 Mn |
| Mar 31, 2026 | 16.84 Mn |
| Dec 31, 2025 | 23.92 Mn |
| Sep 30, 2025 | 32,239.64 Bn |
| Jun 30, 2025 | 28.89 Mn |
| Mar 31, 2025 | 15.25 Mn |
| Dec 31, 2024 | 10.58 Mn |
| Sep 30, 2024 | 9.47 Mn |
| Jun 30, 2024 | 8.39 Mn |
| Mar 31, 2024 | 15.36 Mn |
| Dec 31, 2023 | 9.79 Mn |
| Oct 31, 2023 | -0.01 |
| Jan 31, 2023 | 9.59 Mn |
| Oct 31, 2022 | 6.73 Mn |
| Oct 31, 2021 | 7.12 Mn |
| Apr 30, 2021 | 4.93 Mn |
| Jan 31, 2021 | 1.56 Mn |
| Oct 31, 2020 | -945,019.00 |
| Jul 31, 2020 | -673,205.00 |
| Apr 30, 2020 | 14.18 Mn |